The modulation of mtDNA copy number by manipulating TFAM levels may provide a future route to treat not only primary mitochondrial diseases but also to intervene in other human pathologies characterized by mitochondrial impairment. Here, TFAM is linked to inborn mitochondrial metabolism disorder.